• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Blue Water Ventures International Inc (OP: BWVI )

    0.0001 UNCHANGED
    Last Price Updated: 11:28 AM EST, Dec 10, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Blue Water Ventures International Inc

    I Saw Trillions Of Atoms In My Hand Vibrating At A Certain Frequency, Says Zappy Zapolin Describing His First Psychedelics Experience
    Via Benzinga
    Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More
    Via Benzinga
    Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
    Via Benzinga
    Shark Tank's Kevin Harrington Leads Crowdfunding Campaign For Psycheceutical Bioscience (OTCPK: BWVI)
    Shark Tank’s Kevin Harrington thinks safe psychedelic medicines without the “trip” are the future of mental health care, and has put his support behind Psycheceutical - Click Here To Invest 
    Via Benzinga
    Treating PTSD Topically & Directly To The Brain? Psychedelics Delivery Company Poised For Major Breakthrough
    Psycheceutical Bioscience, Inc (OTCPK: BWVI) is a cutting-edge biotech startup that developed a topical drug delivery system called NeuroDirect, a system that can be used to deliver psychedelic drugs... 
    Via Benzinga
    Video: 'Moms On Mushrooms Are Gonna Change The Whole Society,' Says Zappy Zapolin Before Presenting Rick Doblin Award
    In a moment of riveting candor at MAPS' Psychedelic Science 2023 conference in Denver, Colorado, Benzinga Cannabis' Lara Goldstein captured the potent essence of Psycheceutical Bioscience Inc (OTC: 
    Via Benzinga
    EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses
    This year’s edition of Benzinga’s Psychedelics Capital Conference hosted some of the most knowledgeable panelists and hot-button discussions currently in the space. 
    Via Benzinga
    Zappy Zapolin Talks Psychedelics And Breakthrough Delivery Methods: The Future Has Arrived And It's Awesome
    Mike ‘Zappy’ Zapolin, Chief Visionary Officer of Psycheceutical Bioscience, Inc (OTCPK: BWVI), whom we'll call Zappy, shared his vision for the future of psychedelics at the... 
    Via Benzinga
    Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More
    MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data 
    Via Benzinga
    This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin's Attention
    Psycheceutical Bioscience (OTC: BWVI), a company focused on developing innovative technologies for the next generation of mental health treatments, recently hosted Rick Doblin, founder and president of... 
    Via Benzinga
    What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
    The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. 
    Via Benzinga
    What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution
    What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution 
    Via News Direct
    Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
    Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses 
    Via Benzinga
    Breakthrough Treatment For PTSD? This Ketamine Cream Showing Promise In Alleviating Symptoms
    Biotech company Psycheceutical Bioscience Inc. 
    Via Benzinga
    Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
    This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established... 
    Via Benzinga
    Benzinga's Psychedelics Capital Conference: Meet An Unrivaled Group Of Advisors And Fund Partners
    The upcoming Psychedelics Capital Conference constitutes Benzinga’s effort to provide an exclusive opportunity to meet, connect with and learn from some of the most knowledgeable people in the space. 
    Via Benzinga
    Psycheceutical Bioscience, Inc (OTCPK: BWVI) Could Be Revolutionizing Psychedelic Health Care By Developing The First Ever Topical Psychedelic Cream To Treat PTSD
    Psycheceutical Bioscience, Inc (OTCPK: BWVI) Could Be Revolutionizing Psychedelic Health Care By Developing The First Ever Topical Psychedelic Cream To Treat PTSD 
    Via News Direct
    Novel Ketamine Topical Cream To Treat PTSD Gets First In-Human Trials
    Psycheceutical Bioscience (OTCPK: BWVI) is advancing its proprietary ketamine topical formulation into clinical studies. The life sciences company has partnered with Australian-based contract research... 
    Via Benzinga
    Zappy Zapolin's Psycheceutical Files Patent, Hopes Ketamine Topical Can Treat PTSD
    Lifesciences biotech company Psycheceutical Bioscience (OTC: BWVI), of which Benzinga’s advisory council member Zappy Zapolin is Chief Vi 
    Via Benzinga
    Zappy Zapolin Of Psycheceutical Bioscience Joins The Benzinga Psychedelics Advisory Council: What You Need To Know
    Zappy Zapolin, Chief Visionary Officer at Psycheceutical Bioscience, Inc. 
    Via Benzinga
    Psychedelic Acquisition: Psycheceutical To Buy Majority Equity Stake In Maryland R&D Company
    Publicly traded psychedelics company Psycheceutical Bioscience Inc. (OTC: BWVI) is signing an exclusive purchase option with end-to-end pharma R&D company Vici Health Sciences’ majority equity stake. 
    Via Benzinga
    EXCLUSIVE: Kevin Harrington Becomes The Latest 'Shark Tank' Judge To Enter The Psychedelics Space
    The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrington, one of the original “sharks” in ABC's “Shark Tank”... 
    Via Benzinga
    Researcher Portrayed In Hollywood Movie By Alec Baldwin Joins Psychedelics Company
    In 2015, the movie ​​Concussion, starring Will Smith and Alec Baldwin, told the true story of a doctor and his fight against the National Football League to... 
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.